Product Strategy

How to Write a Product Strategy That Actually Gets Implemented

A practitioner's method for writing a product strategy that survives contact with the organization: diagnose first, size the stakes, make real choices, write a guiding policy, sequence the actions, then do the adoption work most strategy documents skip.

2 November 2026 16 min read
On this page

Most product strategies die in a shared drive. They are written with care, presented once, praised politely, and then ignored by the roadmap that follows. The people who wrote them move on to the next document, and the product team keeps building whatever the loudest customer or the nearest executive asked for.

The strategies that do get implemented share a few qualities that have little to do with how elegant the document is. They start from a real problem. They make choices that someone could disagree with. They are small enough to remember. And, critically, their author treated adoption as part of the work, not something that happens to the document afterwards.

I learned this on both sides of the table. Four years in strategy consulting taught me how to structure a recommendation. Years inside a NYSE-listed company, advising the COO and leadership team, taught me what it takes for one to be acted on. One recommendation of mine, a unified product-experience redesign to replace a fragmented multi-product setup, was implemented company-wide in August 2021. What shipped it was not the elegance of the document. It was that the decision had been made easy to take.

This is the method I follow. It has eight steps, a list of the failure modes I see most, and a template at the end you can adapt. If you want the boundary between strategy and the documents around it, read product strategy vs roadmap vs vision alongside this one. If you are weighing whether to bring in outside help, what a product strategy consultant does covers that decision.

What a product strategy is, and what it is not

The clearest definition I know comes from Richard Rumelt’s book on strategy. A good strategy has a kernel with three parts: a diagnosis that names the challenge, a guiding policy that says how you will deal with it, and a set of coherent actions that carry out the policy. Everything else in a strategy document is supporting material.

That structure rules out several things people call strategy.

A goal is not a strategy. “Reach 10 million in annual recurring revenue” is a destination. It does not say how.

A list of features is not a strategy. It is an output of one. A feature list tells you what you will build, not why those things and not others.

A vision is not a strategy. A vision describes where you want to be and why it matters. It is necessary and not sufficient, which is why the vision, strategy and roadmap each need to exist and to do different jobs.

A platitude is not a strategy. “Delight our customers and win through great experience” cannot be wrong, so it cannot guide anything. Here is my test for any strategic statement: could a smart competitor reasonably choose the opposite? If nobody would ever pick the other side, you have written a value, not a choice.

A real strategy is a set of deliberate trade-offs. It tells people what you will do, and it tells them, by implication, what you will not do. The second part is the one that makes it useful, and the one that makes it uncomfortable.

Step 1: Start with the diagnosis

The most common mistake is to begin with the solution. A team arrives at a strategy session with a favorite idea, and the document becomes a justification for it. I start the other way round, with a diagnosis: a short, evidence-backed statement of what is actually going on.

A good diagnosis has four properties.

It is specific. “Our onboarding is weak” is a complaint. “Sixty percent of new accounts never reach their first successful use, and the drop happens between sign-up and the first integration” is a diagnosis. Numbers help, but so does naming the mechanism.

It is causal. It says why the thing is happening, not just that it is. The best diagnoses reduce a mess of symptoms to one or two underlying causes.

It is falsifiable. You should be able to say what evidence would show you were wrong. If nothing could disprove it, it is an opinion.

It is short. If it needs more than a page, you have not found the cause yet.

At Chegg, the problem the redesign addressed was a fragmented multi-product setup. The case for replacing it rested on evidence from several directions at once, including a UX and UI benchmark of four close competitors, alongside customer, market and internal research. A diagnosis built from one source is an opinion. A diagnosis that several independent sources point to is something a leadership team can act on.

Those three streams are the toolkit I reach for every time:

  • Customer evidence. Interviews, surveys, and behavior data, designed so they can falsify your hunches. My notes on consumer research methods and win-loss analysis describe the rigor that matters.
  • Market and competitor evidence. Where demand is moving, what competitors ship, and how the alternatives compare. This is the work behind competitive intelligence that moves decisions.
  • Internal evidence. Funnel data, cohort behavior, support tickets, sales notes. Your own numbers are often the most underused source.

A habit that pays off: write the diagnosis before you generate any solutions, and share it with a skeptical colleague. If they cannot restate it in their own words, it is not clear enough yet.

Step 2: Size the stakes

A diagnosis tells you what is wrong. The next question is how much it matters, because the answer decides how much effort the strategy deserves.

I do this in two passes.

The size of the opportunity. How large is the prize if you solve the problem? For a market question, that means a bottom-up market sizing built from the customers who could really buy, the price they would pay and the share you could realistically win, not a borrowed top-down figure. You can run the arithmetic with the market sizing calculator. For an existing product, it means quantifying the leak: what the drop in conversion, retention or expansion costs you each month.

The size of the downside. What does it cost to be wrong, and how reversible is the decision? A reversible, cheap decision should be tested, not strategized. An irreversible one deserves real diligence, closer to the discipline in commercial due diligence, which is a method for testing whether a story is true before you commit to it.

Two numbers anchor most of these conversations. Unit economics tell you whether growth in the proposed direction is profitable, and I would not finish a strategy without pressure-testing them with an LTV and CAC analysis. And a business case, even a rough one, converts the argument from opinions to assumptions. The assumptions are the interesting part: list the three that, if wrong, would sink the case, and plan to test them first.

Step 3: Choose where to play and how to win

Now the actual choices. The framework I find most useful for structuring them is the strategy cascade from Roger Martin and A.G. Lafley’s work on strategy, usually called Playing to Win. It asks five connected questions: what is our winning aspiration, where will we play, how will we win, what capabilities do we need, and what management systems will support it.

You do not need to produce a formal cascade. The two middle questions, where to play and how to win, are where most product strategies live or die.

Where to play

This is the set of customers, problems, geographies, channels and product areas you will serve, and, just as important, the ones you will not. Be explicit about the exclusions. A strategy that lists what you will do and omits what you will stop doing has not made a choice.

Segments are usually the cleanest lever. Pick the customer you can serve better than anyone else and say why. “Small businesses” is not a choice. “Owner-managed businesses under twenty employees who handle their own invoicing” is.

How to win

The question is what gives you an advantage in the segment you chose. The best framework I know for this is Hamilton Helmer’s seven powers: scale economies, network economies, counter-positioning, switching costs, branding, cornered resources, and process power. His point is that durable advantage comes from a specific mechanism that lets you earn returns a competitor cannot easily copy.

For a product team, the practical version is a short list of questions:

  • What do we do that is hard for a competitor to replicate quickly?
  • Does the product get better, cheaper or stickier as it grows?
  • Do customers face real costs to leave, or do they stay out of habit?
  • Is our advantage in the product, in distribution, in data, or in trust?

The last question matters because, as I note in commercial due diligence, incumbency and a moat look similar from the outside. Customers who stay only because switching is annoying are not an advantage. They are a risk waiting for a better competitor.

Write down what you will not do

Pick at least three things the strategy rules out. They should be things a reasonable team might otherwise do. If your list of exclusions contains nothing anyone wants, it is decoration. The useful ones sting: a segment sales keeps chasing, a feature a loud customer keeps requesting, a market that looks attractive and is not.

Step 4: Write the guiding policy

The guiding policy is the heart of the document and should fit in a few sentences. It is the approach you will take to the problem named in the diagnosis, and it should work as a decision filter: when someone proposes a project six months from now, the policy should help you say yes or no without a meeting.

Compare two versions.

Weak: “We will build a best-in-class platform that delights customers and drives growth.”

Strong (illustrative): “We will present one coherent experience across our products, starting with the places customers move between them, and we will stop shipping features that exist in only one product unless they are on the path to sharing.”

The strong version names the approach, sets a priority, and creates a rule. Anyone can use it to judge a proposal.

Two techniques make policies sharper.

Trade-off rules. State what wins when two good things conflict. “When speed to market conflicts with consistency, consistency wins in the shared layer and speed wins in the product-specific layer.” These rules settle disputes before they happen, and they are how a strategy becomes a daily tool.

Design principles. Three to five short statements that describe how you will build. They are less binding than the policy and more concrete than the vision, and they give teams a shared language for local decisions.

Step 5: Turn the policy into coherent actions

A policy with no actions is a wish. The actions are what turn the strategy into movement, and the word that matters is coherent: they should reinforce each other, rather than being a collection of good ideas that happen to share a deadline.

For each action, I want five things written down.

  1. What exactly will happen.
  2. Who owns it, one person, not a team.
  3. When it starts, what it depends on, and when we will know whether it worked.
  4. How we will measure it. A leading indicator we can read early and a lagging outcome we care about.
  5. What would make us stop. A pre-agreed signal that tells us the action is not working.

The sequencing deserves attention. Order actions so that early ones produce proof and reduce risk for later ones. For a redesign, that might mean starting with the shared foundations and the highest-traffic flow, so the organization can see value before it is asked to commit more. Sequencing is also where strategy hands over to the roadmap. I explain exactly where that boundary sits in product strategy vs roadmap vs vision, and how to build a roadmap that survives contact with reality in building a growth roadmap.

On metrics, resist the urge to measure everything. One north star metric tied to the strategy, plus a small number of leading indicators, is enough. If the strategy involves experiments, prioritize them honestly with a method like those in experiment prioritization and run them through a disciplined A/B testing program. Each experiment should teach you something about whether the strategy’s core assumptions hold.

Step 6: Pressure-test it before you publish it

Before the document leaves your hands, attack it. I use four exercises, none of which take long.

The strongest objection. Write the best argument against your own strategy, as if you were a smart competitor or a skeptical board member. If you cannot make the case convincingly, you do not yet understand the alternative. Include the objection and your answer in the document. It builds trust, and it shows you did the work.

The pre-mortem. Imagine it is a year from now and the strategy has failed. Write the three most likely reasons. Then check whether the plan guards against them. Pre-mortems surface risks that optimism normally hides, and they are easier for teams to do because the failure is hypothetical.

The assumption audit. List the assumptions the strategy depends on and rate each by how confident you are and how costly it would be if wrong. The high-impact, low-confidence ones are your first experiments.

The inconsistency check. Do the diagnosis, the policy and the actions agree with each other? When they do not, one of them is wrong, and the disagreement is itself a finding. This is the same check I run on a deal in diligence, where a market view, a customer view and a set of projections that do not fit together mean at least one is not true.

Step 7: Do the adoption work

Here is the step most strategy documents omit, and the reason most strategies fail. Adoption is not something that happens after the strategy is finished. It is part of the strategy. If you treat a recommendation as a product, adoption is distribution.

What I do, in rough order:

Map the people. Who decides, who influences, who must change what they do, and who loses something. Be honest about the last group. A strategy that quietly removes someone’s project will meet resistance, and it is better to know in advance.

Pre-wire. Never present the strategy for the first time in the meeting where it is decided. Talk to the key people one by one beforehand. Understand their concerns, adjust where they are right, and let them see their input in the document. By the decision meeting, the room should already largely agree.

Make the decision easy to take. Frame it as a decision, with options considered, a recommendation, the reasoning, the risks and a stated confidence level. People accept a recommendation more readily when it shows its uncertainty honestly than when it claims a certainty nobody believes. I covered the same principle in commercial due diligence: separate what you know from what you believe.

Get an early, visible win. A small piece of the strategy delivered quickly turns an abstract plan into something the organization can see working. It also builds the credibility you need for the harder parts.

Treat rollout as change management. New ways of working need training, documentation, support and a place to ask questions. When I led change for four new platforms at Chegg, vendor best-practice sessions, stakeholder training, new support processes and documentation produced 100% stakeholder buy-in. That is the same toolkit a strategy rollout needs, and I describe it in change management for new martech.

Write it down once, where people will find it. A short, clear document in one place. When the strategy lives in six slide decks, nobody knows which is current.

Step 8: Keep it alive

A strategy is a hypothesis about how to win, and the market will test it. Plan for that.

Set a review cadence, quarterly for most teams, with a short agenda: what we learned, which assumptions held, which did not, and what we are changing. Reviews should be about the strategy, not the status of projects.

Define update triggers in advance, events that should prompt a rethink even between reviews. A competitor launching a rival feature, a shift in unit economics, a regulatory change, a major customer loss.

Keep a decision log. Record each significant choice, the reasoning at the time and the assumptions behind it. When circumstances change, you can see which parts of the logic still hold and which do not, instead of arguing from memory.

And be willing to change your mind in public. A team that never revises its strategy is either extraordinarily lucky or not paying attention. Revision is not failure. It is the strategy doing its job.

The failure modes I see most

Strategy by wish list. Every stakeholder gets a line, nothing is cut, and the document describes everything and decides nothing.

Diagnosis skipped. The solution arrived first, and the evidence was selected to support it.

No exclusions. If it does not say no to anything, it is not a choice.

Metrics with no decisions behind them. A dashboard is not a strategy.

One-off ceremony. A big offsite and a polished deck, followed by nothing. The strategy has to change how decisions are made on a Tuesday afternoon.

The author disappears. Strategy handed over without a person who owns adoption tends to drift. Someone has to carry it.

Over-engineering. A forty-page document that nobody finishes loses to a two-page one that everybody has read.

A template you can adapt

Here is the skeleton I use for a product strategy document. Aim for two to four pages.

  1. The challenge. The diagnosis in one page or less, with the key evidence.
  2. The stakes. What it is worth and what being wrong costs.
  3. Where we will play, and where we will not.
  4. How we will win. The source of advantage, in plain terms.
  5. The guiding policy. Three to five sentences, plus any trade-off rules.
  6. Coherent actions. A short list with owners, dates, measures and stop signals.
  7. Risks and the strongest objection. With your answers.
  8. How we will adopt it. Stakeholders, communication, early win, rollout.
  9. Review cadence and update triggers.

If every section is complete, concrete and fits on a page or less, you have a strategy people can use.

The short version

  • A strategy is a set of choices, with a kernel of diagnosis, guiding policy and coherent actions. A goal, a feature list and a vision are not strategies.
  • Start with a specific, causal, falsifiable, short diagnosis built from customer, market and internal evidence.
  • Size the opportunity and the downside before you decide how much effort to spend.
  • Choose where to play and how to win, and write down what you will not do.
  • Express the guiding policy in a few sentences that work as a decision filter, with trade-off rules.
  • Turn it into coherent actions with owners, measures and stop signals, sequenced so early steps produce proof.
  • Pressure-test with the strongest objection, a pre-mortem, an assumption audit and a consistency check.
  • Treat adoption as part of the strategy: map people, pre-wire, make the decision easy, win early, and manage the rollout like a change program.
  • Review it on a cadence and change it when the evidence says so.

Where to go next

The most useful companion to this post is product strategy vs roadmap vs vision, which draws the lines between the three documents and shows how a decision moves between them. If your strategy involves AI and you are unsure where models belong in the product, read AI product strategy. And if you would like a second pair of eyes on a decision that is in front of you right now, product strategy consulting explains how that kind of engagement works.


I am Deepanshu Grover, a Senior Product Strategy Consultant in Paris. I take ambiguous, high-stakes product and business questions, run the analysis, and see the recommendation implemented. If you are working on a strategy, connect on LinkedIn or get in touch.

About the author

Deepanshu Grover

Growth Product Manager in Paris. I find the broken or underused lever in a business and rebuild it into a growth channel.

Keep reading